Business Description
DKSH Holding Ltd
NAICS : 561499
ISIN : CH0126673539
Compare
Compare
Traded in other countries / regions
DKSH.SwitzerlandDKSHz.UKDS5.GermanyDKSHF.USA Index Membership
STOXX Europe 600STOXX Europe 600 IPO Date
2012-03-20Description
DKSH Holding Ltd offers market expansion services in Asia. The company's services include sourcing, marketing, sales, distribution, and after-sales service. DKSH operates in five business segments: Consumer goods, Healthcare, Performance Materials, Technology and Other (non-Business Unit). The maximum segment by revenue, Healthcare, specializes in expansion services such as product registration, marketing, distribution, and sales for pharmaceuticals, consumer health, and over-the-counter health products as well as medical devices.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | 1.78 | |||||
Interest Coverage | 10.21 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.41 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 1.3 | |||||
3-Year EPS without NRI Growth Rate | 3.8 | |||||
3-Year FCF Growth Rate | -1.7 | |||||
3-Year Book Growth Rate | 0.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 9.07 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.36 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.73 | |||||
9-Day RSI | 45.44 | |||||
14-Day RSI | 44.97 | |||||
3-1 Month Momentum % | -5.59 | |||||
6-1 Month Momentum % | -4.61 | |||||
12-1 Month Momentum % | 4.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.33 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 48.16 | |||||
Days Sales Outstanding | 67.07 | |||||
Days Payable | 85.77 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.8 | |||||
Dividend Payout Ratio | 0.69 | |||||
3-Year Dividend Growth Rate | 4.9 | |||||
Forward Dividend Yield % | 3.8 | |||||
5-Year Yield-on-Cost % | 4.65 | |||||
Shareholder Yield % | 7.44 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 14.82 | |||||
Operating Margin % | 2.96 | |||||
Net Margin % | 1.94 | |||||
EBITDA Margin % | 4.26 | |||||
FCF Margin % | 2.9 | |||||
ROE % | 12.34 | |||||
ROA % | 3.82 | |||||
ROIC % | 9.41 | |||||
3-Year ROIIC % | 8.19 | |||||
ROC (Joel Greenblatt) % | 35.04 | |||||
ROCE % | 13.61 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.73 | |||||
Forward PE Ratio | 16.75 | |||||
PE Ratio without NRI | 18.95 | |||||
Shiller PE Ratio | 19.05 | |||||
Price-to-Owner-Earnings | 13.98 | |||||
PEG Ratio | 4.99 | |||||
PS Ratio | 0.36 | |||||
PB Ratio | 2.21 | |||||
Price-to-Tangible-Book | 4.01 | |||||
Price-to-Free-Cash-Flow | 12.52 | |||||
Price-to-Operating-Cash-Flow | 11.08 | |||||
EV-to-EBIT | 12.47 | |||||
EV-to-Forward-EBIT | 10.97 | |||||
EV-to-EBITDA | 9.13 | |||||
EV-to-Forward-EBITDA | 7.74 | |||||
EV-to-Revenue | 0.39 | |||||
EV-to-Forward-Revenue | 0.34 | |||||
EV-to-FCF | 13.48 | |||||
Price-to-GF-Value | 0.9 | |||||
Price-to-Projected-FCF | 0.99 | |||||
Price-to-Median-PS-Value | 0.87 | |||||
Price-to-Graham-Number | 1.84 | |||||
Price-to-Net-Current-Asset-Value | 11.04 | |||||
Earnings Yield (Greenblatt) % | 8.02 | |||||
FCF Yield % | 8 | |||||
Forward Rate of Return (Yacktman) % | 11.06 |